All Work

Chris Lange

Will Frozen 2 Be Bigger Than the Original?

Disney posted another big win at the box office with its most recent movie “Frozen 2,” which looks to capitalize on the success of the original, and so far it’s off to a strong…

Chris Lange · 7 years ago

Why This Atopic Dermatitis Study Was So Well Received

Aslan Pharmaceuticals shares jumped on Monday after the firm announced positive preliminary data from the lowest dose cohort of its ongoing multiple ascending dose study of its treatment of moderate-to-severe atopic dermatitis.

Chris Lange · 7 years ago

Why This Seizure Treatment Could Be the Next Big Thing

Aquestive Therapeutics shares jumped early on Monday after the firm announced the completion of its rolling submission of a New Drug Application (NDA) to the FDA for its therapeutic candidate Libervant.

Chris Lange · 7 years ago

Why Autodesk Earnings Are So Great

Autodesk released its fiscal third quarter financial results after the markets closed on Tuesday. The firm said that it had $0.78 in earnings per share (EPS) and $843 million in revenue, compared with consensus…

Chris Lange · 7 years ago

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.

Chris Lange · 7 years ago

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange · 7 years ago

HP Slides By in Q4

HP released its fiscal fourth-quarter financial results after the markets closed on Tuesday. The firm said that it had $0.60 in earnings per share (EPS) and $15.4 billion in revenue, compared with consensus estimates…

Chris Lange · 7 years ago

What This Study For ANCA Vasculitis Means Going Forward

ChemoCentryx shares more than tripled on Tuesday after the firm, in conjunction with Vifor Fresenius Medical Care Renal Pharma, announced positive topline data from its late-stage trial of avacopan for the treatment of patients…

Chris Lange · 7 years ago

What to Expect When HP Reports After the Close

HP is scheduled to release its fiscal fourth quarter financial results after the markets close on Tuesday. The consensus estimates are calling for $0.58 in earnings per share (EPS) and $15.27 billion in revenue.…

Chris Lange · 7 years ago

Why This Newly FDA Approved Sickle Cell Treatment Will Be Huge

Global Blood Therapeutics shares jumped on Tuesday after the firm announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta (voxelotor) tablets for the treatment of sickle cell disease…

Chris Lange · 7 years ago

Is Dollar Tree in Trouble This Holiday Season?

Dollar Tree reported its fiscal third-quarter results before the markets opened on Tuesday. The discount retailer posted $1.08 in earnings per share (EPS) and $5.75 billion in revenue, almost in line with the consensus…

Chris Lange · 7 years ago

Are Palo Alto Earnings Enough to Offset Guidance?

Palo Alto Networks released its fiscal first quarter financial results after the markets closed on Monday. The firm said that it had $1.05 in earnings per share (EPS) and $772 million in revenue, compared…

Chris Lange · 7 years ago

6 Top Picks for 2020 Technology Spending Trends

In a recent report, Nomura highlighted that webscale spending growth is accelerating in the U.S. As a result, Nomura has picked some companies that it sees benefiting the most from the growth in webscale…

Chris Lange · 7 years ago